Optician India

Uncorrected refractive error (URE) remains one of the leading causes of visual impairment globally and in India, despite being easily correctable with appropriate spectacles.

India’s optical sector may be approaching a defining moment. A recent Private Member Bill introduced in March 2026 by Dr. Ajeet Madhavrao Gopchade proposes a Central Optical Devices Quality Control & Vision Care Regulation framework signals a potential policy shift in India’s approach to vision care. In this context, I wish to dwell on the implications of this legislative initiative in the context of the World Health Organization’s SPECS 2030 strategy and outlines a pathway to align regulation with access, quality, and equity.

A Sector in a Regulatory Grey Zone

Despite serving millions, India lacks unified standards governing spectacle quality, dispensing practices, and accountability.

What the Bill Signals

The Bill reflects a shift from treating spectacles as retail products to recognising them as assistive healthcare devices.

The Opportunity

Improved quality, enhanced consumer trust, and alignment with frameworks such as the National Commission for Allied and Healthcare Professions Act, 2021.

The Risk

Over-regulation could increase costs, burden small opticians, and blur distinctions between prefabricated readers and custom prescription spectacles.

Access vs Control

India’s diverse market requires a balance between quality assurance and accessibility, especially in rural and Tier 2/3 markets.

The Way Forward

Collaboration between government, industry, and healthcare bodies is essential for practical and scalable regulation.

Conclusion

This Bill has initiated an important policy conversation. With the right approach, it can significantly strengthen India’s vision care ecosystem.